respiratori
syncyti
viru
rsv
human
paramyxoviru
import
caus
viral
lower
respiratori
tract
diseas
infant
children
worldwid
primari
rsv
bronchiol
caus
substanti
morbid
mortal
cost
hospit
admiss
rate
high
proport
infant
develop
recurr
episod
wheez
cough
asthmalik
symptom
recoveri
bronchiol
interest
therefor
focus
role
host
immun
respons
pathogenesi
bronchiol
clinic
sequela
immunopathogenesi
rsv
bronchiol
play
import
part
clinic
manifest
primari
infect
evid
human
mous
studi
suggest
lymphocyt
clear
rsv
infect
children
cellmedi
immunodefici
take
longer
termin
infect
rsv
mous
model
graham
et
al
studi
effect
deplet
lymphocyt
acut
rsv
infect
lymphocyt
subset
involv
termin
primari
infect
lymphocyt
subset
deplet
rsv
shed
prolong
howev
deplet
lymphocyt
mice
also
reduc
clinic
symptom
lung
injuri
research
increas
patholog
recipi
formalininactiv
rsv
vaccin
implic
aberr
lymphocyt
mediat
data
suggest
lymphocyt
may
also
play
role
caus
lung
patholog
rsv
infect
previou
review
comment
white
cell
count
rsv
bronchiol
vari
preponder
neutrophil
strike
chang
circul
white
cell
count
reduct
lymphocyt
number
effect
pronounc
sicker
children
suggest
reduct
lymphocyt
count
due
redistribut
lung
howev
lymphopenia
also
known
occur
viral
ill
includ
measl
sever
acut
respiratori
syndrom
sar
ebola
data
suggest
apoptosi
lymphocyt
occur
ill
may
offer
mechan
lymphocyt
declin
apoptosi
program
cell
death
via
number
regul
energydepend
pathway
two
key
apoptot
cascad
far
identifi
import
remov
matur
circul
lymphocyt
death
receptor
mediat
mitochondrialdepend
cell
surfac
death
receptor
includ
fa
tumour
necrosi
factorrel
apoptosisinduc
ligand
trail
receptor
activ
bind
specif
ligand
fa
ligand
trail
pathway
lead
activ
cascad
specif
proteolyt
enzym
caspas
caus
cell
die
fa
ligand
may
membran
bound
solubl
sfa
ligand
solubl
form
may
mediat
fasdepend
apoptosi
bystand
cell
pathway
apoptosi
inflamm
intertwin
convert
inact
molecul
activ
cytokin
respect
activ
immun
system
stimul
chemokin
releas
develop
respons
affect
apoptosi
upregul
fa
studi
infant
admit
hospit
rsv
bronchiol
undertook
find
evid
support
refut
hypothesi
circul
lymphocyt
may
undergo
apoptosi
result
suggest
rsv
diseas
may
associ
lymphocyt
apoptosi
offer
novel
mechan
rsv
may
alter
longterm
immun
respons
studi
protocol
approv
addenbrook
hospit
cambridg
local
region
ethic
committe
infant
includ
studi
admit
hospit
diagnosi
bronchiol
month
age
younger
rsv
posit
routin
nasopharyng
aspir
immunofluoresc
parent
gave
written
inform
consent
purpos
studi
clinic
diagnosi
bronchiol
also
includ
requir
supplement
oxygen
maintain
arteri
satur
greater
blood
sampl
taken
within
h
admiss
known
parent
recollect
day
child
symptom
began
unreli
chose
state
day
ill
blood
sampl
howev
day
admiss
hospit
usual
close
peak
clinic
symptom
attempt
obtain
blood
sampl
close
time
possibl
children
suspect
known
immunodefici
exclud
studi
parent
ask
return
child
convalesc
blood
sampl
month
follow
acut
ill
sampl
taken
immedi
laboratori
analysi
process
taken
blood
sampl
heparin
edta
sampl
taken
full
blood
count
white
cell
differenti
plasma
separ
heparin
sampl
frozen
remain
cellular
compon
resuspend
phosphatebuff
salin
ph
supplement
human
albumin
pbsa
lymphocyt
obtain
densiti
gradient
separ
histopaqu
sigma
pool
uk
resuspend
pbsa
concentr
lymphocyt
incub
monoclon
antibodi
beckman
coulter
rpe
dakocytom
uk
pe
caltagmedsystem
uk
red
caltag
dakocytom
trail
rpe
pharmingen
four
colour
combin
incub
dark
room
temperatur
min
stain
cell
wash
twice
pbsa
analys
beckman
coulter
epic
xl
flow
cytomet
use
system
ii
softwar
standard
lymphocyt
gate
set
use
low
forward
side
scatter
properti
posit
posit
region
set
isotyp
match
control
express
allow
extent
red
cell
contamin
gate
region
assess
result
correct
accordingli
result
express
percentag
mean
fluoresc
intens
flow
cytometr
data
analys
use
winmdi
version
softwar
plasma
level
solubl
fa
ligand
assay
measur
commerci
avail
enzymelink
immunosorb
assay
kit
solubl
fa
ligand
diaclon
id
ltd
uk
r
system
europ
ltd
uk
alexi
corpor
uk
ltd
valu
report
median
interquartil
rang
iqr
confid
limit
median
use
box
whisker
plot
data
analys
use
test
nonparametr
data
pvalu
consid
signific
thirtytwo
infant
girl
boy
enrol
studi
characterist
summar
tabl
thirteen
children
requir
endotrach
intub
mechan
ventil
respiratori
failur
admit
paediatr
intens
care
unit
picu
part
admiss
primari
apnoea
indic
ventil
patient
nineteen
children
requir
paediatr
ward
admiss
supplement
oxygen
therapi
fluid
manag
overal
median
iqr
group
kg
weight
week
age
admiss
week
gestat
birth
common
previou
studi
children
admit
picu
younger
p
weigh
less
p
lower
gestat
age
birth
p
children
surviv
ill
discharg
home
acut
cohort
infant
return
convalesc
blood
sampl
mean
week
acut
ill
followup
cohort
girl
boy
children
requir
picu
admiss
due
design
studi
followup
infant
averag
month
older
correspondingli
heavier
acut
group
one
patient
cohort
white
cell
differenti
count
obtain
absolut
number
lymphocyt
reduc
rsv
bronchiol
p
lymphocyt
p
p
lymphocyt
significantli
reduc
ill
tabl
acut
ill
lymphocyt
upregul
fa
compar
sampl
taken
convalesc
p
proport
stain
high
fa
median
fluoresc
intens
increas
fig
lymphocyt
also
express
higher
level
surfac
fa
p
compar
convalesc
sampl
fig
trail
receptor
also
regul
popul
p
popul
p
fig
b
support
hypothesi
increas
express
death
receptor
lymphocyt
associ
lymphopenia
perform
linear
regress
analysi
level
fa
express
correl
count
p
fig
plasma
level
sfa
ligand
significantli
higher
acut
sampl
compar
convalesc
sampl
p
fig
plasma
level
significantli
higher
acut
sampl
convalesc
sampl
p
statist
signific
differ
plasma
level
acut
convalesc
sampl
median
within
normal
report
rang
healthi
adult
fig
lymphocyt
subset
acut
ill
analys
respect
age
absolut
lymphocyt
count
p
p
p
p
count
invers
relat
age
fig
relationship
age
lymphocyt
count
convalesc
sampl
studi
look
evid
lymphocyt
apoptosi
may
mechan
rsvinduc
lymphopenia
found
absolut
count
helper
cell
cytotox
lymphocyt
reduc
rsv
bronchiol
also
demonstr
upregul
express
cell
surfac
receptor
fa
trail
receptor
lymphocyt
increas
plasma
level
sfa
ligand
acut
ill
increas
fa
express
correl
lymphopenia
direct
evid
intravascular
apoptosi
sought
sinc
small
quantiti
blood
obtain
critic
ill
babi
preclud
use
direct
assay
dna
ladder
taken
togeth
find
suggest
death
receptormedi
apoptosi
involv
reduct
lymphocyt
number
diseas
data
show
invers
correl
age
suggest
may
critic
period
infanc
effect
pronounc
demonstr
elev
plasma
acut
ill
import
determin
lymphocyt
phenotyp
link
modul
apoptosi
result
may
also
implic
lymphocyt
function
regul
apoptosi
alreadi
report
lymphopenia
pronounc
sicker
children
de
weerd
et
al
studi
children
age
year
acut
rsv
bronchiol
show
signific
reduct
cell
infect
infant
reduct
lymphocyt
subset
ventil
data
also
found
nonsignific
reduct
total
lymphocyt
count
rsv
posit
patient
roman
et
al
found
nonsignific
reduct
total
tlymphocyt
subset
larger
size
studi
group
inclus
sever
affect
infant
may
help
explain
clearer
find
rsv
predominantli
infect
respiratori
epitheli
cell
shown
vitro
infect
type
pneumocyt
rsv
lead
apoptosi
increas
level
fa
fasligand
express
demonstr
infect
cell
rsv
mediat
upregul
nuclear
transcript
factor
reversetranscriptas
polymeras
chain
reaction
rtpcr
use
show
rsv
viral
mrna
detect
pbmc
small
number
infant
acut
bronchiol
howev
extens
decreas
number
lymphocyt
unlik
explain
directli
infect
cell
low
level
suggest
bystand
apoptosi
may
import
measl
apoptosi
uninfect
lymphocyt
also
associ
upregul
cell
surfac
express
fa
trailr
lymphocyt
apoptosi
occur
infect
ebola
viru
may
close
genet
link
rsv
bystand
lymphocyt
apoptosi
occur
sever
sepsi
mous
model
sever
sepsi
block
apoptosi
specif
caspas
inhibitor
associ
improv
outcom
although
model
differ
natur
infect
data
mice
suggest
possibl
futur
clinic
therapeut
intervent
studi
coronaviru
associ
sever
acut
respiratori
syndrom
sar
lymphopenia
describ
hallmark
laboratori
find
reason
lymphopenia
unknown
panesar
offer
suggest
use
steroid
loss
vascular
integr
may
contribut
data
would
indic
lymphocyt
apoptosi
might
target
futur
studi
diseas
differ
subset
cell
believ
differ
suscept
apoptosi
atop
dermat
data
suggest
apoptot
cell
death
may
remov
cell
allow
respons
becom
domin
way
lymphocyt
apoptosi
may
offer
mechan
gener
longterm
immun
memori
may
alter
debat
caus
longterm
cough
wheez
bronchiol
lead
polar
view
children
hospit
rsv
bronchiol
increas
risk
allerg
sensit
compar
control
evid
anim
model
rsv
associ
allerg
sensit
mainten
airway
hyperrespons
earli
allerg
sensit
identifi
key
risk
factor
persist
asthma
role
virus
earli
life
remain
controversi
cell
mediat
immun
includ
prolifer
cytotox
memori
cytokin
product
may
affect
rsv
infect
preston
et
al
shown
cell
prolif
respons
may
inhibit
rsv
rsv
inhibit
cell
infiltr
lung
develop
tcell
memori
mous
model
differ
protein
rsv
shown
prime
specif
lymphocyt
subset
surfac
glycoprotein
g
associ
induct
type
cell
lung
eosinophilia
rsv
infect
import
earli
cytokin
togeth
regul
product
promot
develop
type
thelper
respons
contrast
absenc
may
stimul
develop
type
immun
respons
data
suggest
level
increas
acut
bronchiol
legg
et
al
shown
lp
stimul
pbmc
children
acut
bronchiol
reduc
mrna
express
compar
children
rsvneg
upper
respiratori
tract
infect
contrast
studi
nasal
secret
infant
rsv
suggest
product
epitheli
cell
may
elev
summari
data
support
hypothesi
lymphopenia
seen
rsv
bronchiol
associ
apoptosi
effect
pronounc
younger
infant
suggest
import
time
infanc
immun
system
may
vulner
reduct
lymphocyt
relat
degre
cellular
express
receptor
apoptosi
find
mirror
sever
sepsi
data
indic
inhibit
apoptosi
may
amelior
ill
futur
dissect
novel
mechan
may
help
delin
delay
effect
rsv
infect
offer
new
therapeut
avenu
